Ataxia telangiectasia overview: Difference between revisions

	Ataxia telangiectasia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ataxia telangiectasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Diagnostic Studies
Treatment
Medical Therapy
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ataxia telangiectasia overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ataxia telangiectasia overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ataxia telangiectasia overview
CDC on Ataxia telangiectasia overview
Ataxia telangiectasia overview in the news
Blogs on Ataxia telangiectasia overview
Directions to Hospitals Treating Ataxia telangiectasia
Risk calculators and risk factors for Ataxia telangiectasia overview

Revision as of 16:00, 10 July 2021

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 6: / Line 6: @@
 == Overview ==
-'''Ataxia-telangiectasia''' (AT) is a primary [[immunodeficiency]] disorder. It is associated with a defect in [[T-cell]]s.<ref name="titleAtaxia-Telangiectasia: Immunodeficiency Disorders: Merck Manual Professional">{{cite web |url=http://www.merck.com/mmpe/sec13/ch164/ch164c.html |title=Ataxia-Telangiectasia: Immunodeficiency Disorders: Merck Manual Professional |accessdate=2008-03-01 |format= |work=}}</ref>
-<br> '''A-T''' is caused by mutations in the '''ATM''' gene on chromosome '''11q22.3'''. It has various clinical and genetic presentations, and 2 types of the disease have been reported. <ref>{{https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590299/}}</ref>
 == References ==